FIX Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at FIX. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by FIX. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsFIXXHomology Medicines$0.56-3.5%4/6/2023Target Lowered byFIX-$19.00 -> $7.00LowView details for FIX rating of Homology Medicines (NASDAQ:FIXX) on 4/6/2023VIVTelefônica Brasil$10.77-0.3%6/8/2022Downgraded byFIX-Buy -> Neutral$56.00HighView details for FIX rating of Telefônica Brasil (NYSE:VIV) on 6/8/2022FIXXHomology Medicines$0.56-3.5%4/6/2022Target Lowered byFIX-$19.00 -> $7.00HighView details for FIX rating of Homology Medicines (NASDAQ:FIXX) on 4/6/2022ABMABM Industries$43.67+0.2%6/29/2021Upgraded byFIX-AddHighView details for FIX rating of ABM Industries (NYSE:ABM) on 6/29/2021FIXComfort Systems USA$194.01+2.7%5/25/2021Reiterated byFIX-SellMediumView details for FIX rating of Comfort Systems USA (NYSE:FIX) on 5/25/2021ATUSAltice USA$2.15+0.9%5/18/2021Downgraded byFIX-Neutral -> Underperform$38.00LowView details for FIX rating of Altice USA (NYSE:ATUS) on 5/18/2021 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TSLATesla$243.84+0.5%3/9/2021Upgraded byFIX-BuyHighView details for FIX rating of Tesla (NASDAQ:TSLA) on 3/9/2021WMTWalmart$150.86-1.0%1/25/2021Downgraded byFIX-Hold -> Sell$157.00 -> $131.00LowView details for FIX rating of Walmart (NYSE:WMT) on 1/25/2021REGNRegeneron Pharmaceuticals$840.14-1.1%1/8/2021Upgraded byFIX-Neutral -> Buy$635.00 -> $575.00MediumView details for FIX rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 1/8/2021FIXComfort Systems USA$194.01+2.7%8/7/2020Reiterated byFIX-SellMediumView details for FIX rating of Comfort Systems USA (NYSE:FIX) on 8/7/2020FIXXHomology Medicines$0.56-3.5%6/25/2020Initiated byFIX-Buy$30.00HighView details for FIX rating of Homology Medicines (NASDAQ:FIXX) on 6/25/2020HRTXHeron Therapeutics$1.49+5.7%5/18/2020Initiated byFIX-AddLowView details for FIX rating of Heron Therapeutics (NASDAQ:HRTX) on 5/18/2020FIXXHomology Medicines$0.56-3.5%3/16/2020Upgraded byFIX-Market Perform -> OutperformHighView details for FIX rating of Homology Medicines (NASDAQ:FIXX) on 3/16/2020INTCIntel$42.70+1.3%1/24/2020Target Raised byFIX-Buy$70.00 -> $75.00HighView details for FIX rating of Intel (NASDAQ:INTC) on 1/24/2020SRSpire$62.88-0.4%1/7/2020Initiated byFIX-Buy$89.00LowView details for FIX rating of Spire (NYSE:SR) on 1/7/2020FIXXHomology Medicines$0.56-3.5%10/31/2019Initiated byFIX-Market PerformHighView details for FIX rating of Homology Medicines (NASDAQ:FIXX) on 10/31/2019ICEIntercontinental Exchange$113.34+0.7%9/16/2019Initiated byFIX-Outperform$100.00MediumView details for FIX rating of Intercontinental Exchange (NYSE:ICE) on 9/16/2019DLTRDollar Tree$124.41-1.8%1/10/2019Downgraded byFIX-Outperform -> Market PerformMediumView details for FIX rating of Dollar Tree (NASDAQ:DLTR) on 1/10/2019TSLATesla$243.84+0.5%10/25/2018Reiterated byFIX-Outperform -> Positive$27.87MediumView details for FIX rating of Tesla (NASDAQ:TSLA) on 10/25/2018EBAYeBay$41.29-0.5%10/22/2018Downgraded byFIX-Buy -> Neutral$44.00 -> $33.00LowView details for FIX rating of eBay (NASDAQ:EBAY) on 10/22/2018ICEIntercontinental Exchange$113.34+0.7%9/5/2018Initiated byFIX-Buy$88.00HighView details for FIX rating of Intercontinental Exchange (NYSE:ICE) on 9/5/2018CROXCrocs$103.74-0.4%4/16/2018Downgraded byFIX-Neutral$12.00HighView details for FIX rating of Crocs (NASDAQ:CROX) on 4/16/2018RDNTRadNet$36.22+0.6%3/14/2018Initiated byFIX-Strong-Buy$15.00HighView details for FIX rating of RadNet (NASDAQ:RDNT) on 3/14/2018NWLNewell Brands$8.42+0.2%2/8/2018Reiterated byFIX-Hold$23.00HighView details for FIX rating of Newell Brands (NASDAQ:NWL) on 2/8/2018HQYHealthEquity$68.48+1.1%3/14/2017Initiated byFIX-OutperformMediumView details for FIX rating of HealthEquity (NASDAQ:HQY) on 3/14/2017EPCEdgewell Personal Care$34.86-1.1%10/5/2016Upgraded byFIX-PositiveN/AView details for FIX rating of Edgewell Personal Care (NYSE:EPC) on 10/5/2016FIXComfort Systems USA$194.01+2.7%10/30/2015Downgraded byFIX-Buy -> HoldN/AView details for FIX rating of Comfort Systems USA (NYSE:FIX) on 10/30/2015ESPREsperion Therapeutics$1.49-5.7%8/17/2015Reiterated byFIX-addN/AView details for FIX rating of Esperion Therapeutics (NASDAQ:ESPR) on 8/17/2015STAGSTAG Industrial$36.22+0.0%5/4/2015Upgraded byFIX-PositiveN/AView details for FIX rating of STAG Industrial (NYSE:STAG) on 5/4/2015 MarketBeat Community Rating for FIXCommunity Ranking: 2.7 out of 5 (2.7 of 5 stars)Outperform Votes: 22,152 (Vote Outperform)Underperform Votes: 18,843 (Vote Underperform)Total Votes: 40,995MarketBeat's community ratings are surveys of what our community members think about FIX and other research firms. Vote "Outperform" if you believe FIX's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FIX's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.